Taiwan FDA registration 1f0c7067b70167eee93a380fb9fb2b67
Wilo quasi-mumps, measles and varicella zoster quality solution
TW: 威樂準 腮腺炎麻疹及水痘帶狀皰疹品管液
Taiwan·Risk Class 2·BIO-RAD LABORATORIES INC.·Registered May 08, 2013 – May 08, 2028ActiveRegistration details
- Analysis ID
- 1f0c7067b70167eee93a380fb9fb2b67
- Customs Code
- DHA00602468501
Company information
- Manufacturer
- BIO-RAD LABORATORIES INC.
- Manufacturer Country
- United States
- Authorized Representative
- Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.)
Product details
- Intended Use
- This product is an unanalyzed reaction quality solution and in vitro diagnostic enzyme immunoassay to determine immunoglobulin G of anti-mumps virus, measles virus and varicella zoster virus.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- import
Dates and status
- Registration Date
- May 08, 2013
- Expiry Date
- May 08, 2028
About this record
Access comprehensive regulatory information for Wilo quasi-mumps, measles and varicella zoster quality solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1f0c7067b70167eee93a380fb9fb2b67 and manufactured by BIO-RAD LABORATORIES INC.. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices